Are there any reasons why obese women should be denied assisted reproductive technologies?

References

• Hedley A, Ogden C, Johnson C et al. Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA291(23), 2847–2850 (2004).
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Welborn TA, Zimmet PZ et al. Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med. J. Aust.178(9), 427–432 (2003).
   PubMed Web of Science ®Google Scholar
• Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum. Reprod.22(4), 912–915 (2007).
   PubMed Web of Science ®Google Scholar
• Hammoud AO, Gibson M, Peterson CM, Hamilton BD, Carrell DT. Obesity and male reproductive potential. J. Androl.27(5), 619–626 (2006).
   PubMedGoogle Scholar
• O’Dowd A. Society issues guidance on IVF. Br. Med. J.333(7567), 517 (2006).
   PubMedGoogle Scholar
• Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? Br. Med. J.332(7539), 434–435 (2006).
   PubMed Web of Science ®Google Scholar
• Dechaud H, Ferron G, Anahory T et al. Obesity and assisted reproduction techniques. Contracept. Fertil. Sex.26(7–8), 564–567 (1998).
   PubMedGoogle Scholar
• Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am. J. Clin. Nutr.71(Suppl. 5), 1242S–1248S (2000).
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod. Biomed. Online12(5), 542–551 (2006).
   PubMed Web of Science ®Google Scholar
• Galtier-Dereure F, Bringer J. Obesity and pregnancy. Ann. Endocrinol. (Paris)63(5), 470–475 (2002).
   PubMedGoogle Scholar
• Bellver J, Busso C, Pellicer A, Remohi J, Simon C. Obesity and assisted reproductive technology outcomes. Reprod. Biomed. Online12(5), 562–568 (2006).
   PubMedGoogle Scholar
• Pelusi C, Pasquali R. Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications. Treat. Endocrinol2(4), 215–230 (2003).
   PubMedGoogle Scholar
• Moran LJ, Norman RJ. The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr. Clin. Care5(6), 290–297 (2002).
   PubMedGoogle Scholar
• Budak E, Fernandez Sanchez M, Bellver J et al. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3–36 with the reproductive system. Fertil. Steril.85(6), 1563–1581 (2006).
   PubMed Web of Science ®Google Scholar
• Pasquali R, Casimirri F, Vicennati V. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum. Reprod.12(Suppl. 1), 82–87 (1997).
   PubMedGoogle Scholar
• Fedorcsak P, Dale PO, Storeng R et al. Impact of overweight and underweight on assisted reproduction treatment. Hum. Reprod.19(11), 2523–2528 (2004).
   PubMed Web of Science ®Google Scholar
• Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J. Assist. Reprod. Genet.17(10), 547–552 (2000).
   PubMed Web of Science ®Google Scholar
• Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. Br. Med. J.321(7272), 1320–1321 (2000).
   PubMed Web of Science ®Google Scholar
• Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta. Obstet. Gynecol. Scand.79(1), 43–48 (2000).
   PubMed Web of Science ®Google Scholar
• Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case–control study. Hum. Reprod.19(7), 1644–1646 (2004).
   PubMed Web of Science ®Google Scholar
• Winter E, Wang J, Davies MJ, Norman R. Early pregnancy loss following assisted reproductive technology treatment. Hum. Reprod.17(12), 3220–3223 (2002).
   PubMed Web of Science ®Google Scholar
• Balen AH, Platteau P, Andersen AN et al. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. Br. J. Obstet. Gynocol.113(10), 1195–1202 (2006).
   Google Scholar
• Lashen H, Ledger W, Bernal AL, Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum. Reprod.14(3), 712–715 (1999).
   PubMed Web of Science ®Google Scholar
• Dechaud H, Anahory T, Reyftmann L et al. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur. J. Obstet.Gynecol. Reprod. Biol.127(1), 88–93 (2006).
   PubMed Web of Science ®Google Scholar
• Nichols JE, Crane MM, Higdon HL, Miller PB, Boone WR. Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil. Steril.79(3), 645–647 (2003).
   PubMed Web of Science ®Google Scholar
• Elenbogen A, Gidoni Y, Michaeli M et al. The role of obesity on the outcome of in vitro fertilization. Fertil. Steril.84(Suppl. 1), S271 (2005).
   Google Scholar
• Fridstrom M, Sjoblom P, Pousette A, Hillensjo T. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin. Eur. J. Endocrinol.136(5), 488–492 (1997).
   PubMedGoogle Scholar
• Styne-Gross A, Elkind-Hirsch K, Scott RT Jr. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil. Steril.83(6), 1629–1634 (2005).
   PubMed Web of Science ®Google Scholar
• Wattanakumtornkul S, Damario MA, Stevens Hall SA, Thornhill AR, Tummon IS. Body mass index and uterine receptivity in the oocyte donation model. Fertil. Steril.80(2), 336–340 (2003).
   PubMedGoogle Scholar
• Bellver J, Rossal LP, Bosch E et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil. Steril.79(5), 1136–1140 (2003).
   PubMed Web of Science ®Google Scholar
• Bellver J, Melo MA, Bosch E et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil. Steril. (2007) [Epub ahead of print].
   Google Scholar
• Servin F. Ambulatory anesthesia for the obese patient. Curr. Opin. Anaesthesiol.19(6), 597–599 (2006).
   PubMedGoogle Scholar
• Dokras A, Baredziak L, Blaine J et al. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet. Gynecol.108(1), 61–69 (2006).
   PubMed Web of Science ®Google Scholar
• Tsagareli V, Noakes M, Norman RJ. Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertil. Steril.86(1), 227–229 (2006).
   PubMedGoogle Scholar
• Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod.13(6), 1502–1505 (1998).
   PubMed Web of Science ®Google Scholar
• Moran LJ, Noakes M, Clifton PM et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab.88(2), 812–819 (2003).
   PubMed Web of Science ®Google Scholar
• Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet369(9555), 71–77 (2007).
   PubMed Web of Science ®Google Scholar
• Jayagopal V, Kilpatrick ES, Holding S, Jennings PE, Atkin SL. Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome. J. Clin. Endocrinol. Metab.90(2), 729–733 (2005).
   PubMed Web of Science ®Google Scholar
• Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst. Rev. (4), CD003641 (2005).
   Google Scholar
• Padwal R. Laparoscopic surgery was better than an intensive non-surgical intervention for weight loss in mild to moderate obesity. Evid. Based Med.11(5), 146 (2006).
   PubMedGoogle Scholar
• Deitel M, Stone E, Kassam HA, Wilk EJ, Sutherland DJ. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J. Am. Coll. Nutr.7(2), 147–153 (1988).
   PubMed Web of Science ®Google Scholar
• Sheiner E, Menes TS, Silverberg D et al. Pregnancy outcome of patients with gestational diabetes mellitus following bariatric surgery. Am. J. Obstet. Gynecol.194(2), 431–435 (2006).
   Google Scholar
• Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet. Gynecol.95(6 Pt 1), 927–930 (2000).
   PubMed Web of Science ®Google Scholar
• Bilenka B, Ben-Shlomo I, Cozacov C, Gold CH, Zohar S. Fertility, miscarriage and pregnancy after vertical banded gastroplasty operation for morbid obesity. Acta Obstet. Gynecol. Scand.74(1), 42–44 (1995).
   PubMed Web of Science ®Google Scholar
• Merhi ZO. Weight loss by bariatric surgery and subsequent fertility. Fertil. Steril.87(2), 430–432 (2007).
   PubMed Web of Science ®Google Scholar
• Hall LF, Neubert AG. Obesity and pregnancy. Obstet. Gynecol. Surv.60(4), 253–260 (2005).
   PubMed Web of Science ®Google Scholar
• Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes. Res.10(6), 551–554 (2002).
   PubMedGoogle Scholar
• Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil. Steril.75(1), 46–52 (2001).
   PubMed Web of Science ®Google Scholar
• Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab.87(2), 524–529 (2002).
   PubMed Web of Science ®Google Scholar
• McTigue KM, Harris R, Hemphill B et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.139(11), 933–949 (2003).
   PubMed Web of Science ®Google Scholar
• Legro RS, Barnhart HX, Schlaff WD et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med.356(6), 551–566 (2007).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P. Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin. Drug. Saf.6(2), 191–198 (2007).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil. Steril.77(3), 520–525 (2002).
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum. Reprod.17(11), 2858–2864 (2002).
   PubMed Web of Science ®Google Scholar